IL23 suppresses proliferation and promotes apoptosis of human granulosa-like tumor cell line KGN by targeting the androgen receptor signal pathway

References

• Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488.
   PubMed Web of Science ®Google Scholar
• Azziz R, Kintziger K, Li R, et al. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource. Hum Reprod. 2019;34(11):2254–2265.
   PubMed Web of Science ®Google Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
   PubMed Web of Science ®Google Scholar
• Baldani DP, Skrgatic L, Ougouag R. Polycystic ovary syndrome: Important underrecognised cardiometabolic risk factor in reproductive-age women. Int J Endocrinol. 2015;2015:786362.
   PubMed Web of Science ®Google Scholar
• Rudnicka E, Suchta K, Grymowicz M, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22(7):3789.
   Web of Science ®Google Scholar
• Piccinni MP, Raghupathy R, Saito S, et al. Cytokines, hormones and cellular regulatory mechanisms favoring successful reproduction. Front Immunol. 2021;12:717808.
   PubMed Web of Science ®Google Scholar
• González F, Considine RV, Abdelhadi OA, et al. Inflammation triggered by saturated fat ingestion is linked to insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;105(6):e2152-2167–e2167.
   Web of Science ®Google Scholar
• Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13(8):722–728.
   PubMed Web of Science ®Google Scholar
• Chyuan IT, Lai JH. New insights into the IL-12 and IL-23: from a molecular basis to clinical application in immune-mediated inflammation and cancers. Biochem Pharmacol. 2020;175:113928.
   PubMed Web of Science ®Google Scholar
• Boniface K, Blom B, Liu YJ, et al. From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev. 2008;226:132–146.
   PubMed Web of Science ®Google Scholar
• Li J, Lau G, Chen L, et al. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression. PLoS One. 2012;7(9):e46264.
   PubMed Web of Science ®Google Scholar
• Calcinotto A, Spataro C, Zagato E, et al. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer. Nature. 2018;559(7714):363–369.
   PubMed Web of Science ®Google Scholar
• Shi SL, Peng ZF, Yao GD, et al. Expression of CD11c + HLA-DR + dendritic cells and related cytokines in the follicular fluid might be related to pathogenesis of ovarian hyperstimulation syndrome. Int J Clin Exp Pathol. 2015;8(11):15133–15137.
   PubMed Web of Science ®Google Scholar
• Zhang QF, Chen GY, Liu Y, et al. Relationship between resistin and IL-23 levels in follicular fluid in infertile patients with endometriosis undergoing IVF-ET. Adv Clin Exp Med. 2017;26(9):1431–1435.
   PubMed Web of Science ®Google Scholar
• Karakose M, Demircan K, Tutal E, et al. Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome. J Endocrinol Invest. 2016;39(11):1269–1275.
   PubMed Web of Science ®Google Scholar
• Spritzer PM, Lecke SB, Satler F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219–227.
   PubMed Web of Science ®Google Scholar
• Regidor PA, Mueller A, Sailer M, et al. Chronic inflammation in PCOS: the potential benefits of specialized pro-resolving lipid mediators (SPMs) in the improvement of the resolutive response. Int J Mol Sci. 2020;22(1):384.
   PubMed Web of Science ®Google Scholar
• Alexiou E, Hatziagelaki E, Pergialiotis V, et al. Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index. Horm Mol Biol Clin Investig. 2017;29(3):105–111.
   PubMed Web of Science ®Google Scholar
• Lim JJ, Lima PDA, Salehi R, et al. Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome. Sci Rep. 2017;7(1):10272.
   Google Scholar
• Livadas S, Pappas C, Karachalios A, et al. Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome. Endocrine. 2014;47(2):631–638.
   PubMed Web of Science ®Google Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219–231.
   PubMed Web of Science ®Google Scholar
• Xu F, Liu R, Cao X. Hyperandrogenism stimulates inflammation and promote apoptosis of cumulus cells. Cell Mol Biol (Noisy-le-Grand). 2017;63(10):64–68.
   PubMed Web of Science ®Google Scholar
• Nehir Aytan A, Bastu E, Demiral I, et al. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(9):709–713.
   PubMed Web of Science ®Google Scholar
• Younas K, Quintela M, Thomas S, et al. Delayed endometrial decidualisation in polycystic ovary syndrome; the role of AR-MAGEA11. J Mol Med (Berl). 2019;97(9):1315–1327.
   PubMed Web of Science ®Google Scholar
• Owens LA, Kristensen SG, Lerner A, et al. Gene expression in granulosa cells from small antral follicles from women with or without polycystic ovaries. J Clin Endocrinol Metab. 2019;104(12):6182–6192.
   PubMed Web of Science ®Google Scholar
• Walters KA, Bertoldo MJ, Handelsman DJ. Evidence from animal models on the pathogenesis of PCOS. Best Pract Res Clin Endocrinol Metab. 2018;32(3):271–281.
   PubMed Web of Science ®Google Scholar
• Li M, Zhao H, Zhao SG, et al. The HMGA2-IMP2 pathway promotes granulosa cell proliferation in polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(4):1049–1059.
   PubMed Web of Science ®Google Scholar
• Rutkowska AZ, Diamanti-Kandarakis E. Polycystic ovary syndrome and environmental toxins. Fertil Steril. 2016;106(4):948–958.
   PubMed Web of Science ®Google Scholar
• Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction. 2001;122(6):829–838.
   PubMed Web of Science ®Google Scholar
• Sun X, Su S, Zhang G, et al. MiR-204 suppresses cell proliferation and promotes apoptosis in ovarian granulosa cells via targeting TPT1 in polycystic ovary syndrome. Biochem Cell Biol. 2019;97(5):554–562.
   PubMedGoogle Scholar
• Shao S, Wang H, Shao W, et al. miR-199a-5p stimulates ovarian granulosa cell apoptosis in polycystic ovary syndrome. J Mol Endocrinol. 2020;65(4):187–201.
   PubMedGoogle Scholar